Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Generic Drugs Market Report 2017

  • QYR884718
  • 111 Pages
  • January 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Generic Drugs

Revenue, means the sales value of Generic Drugs

This report studies sales (consumption) of Generic Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Teva Pharma.

Novartis company

Mylan

Allergan

Hospira

Dr. Reddy’s Lab.

Stada

Greenstone

Par Pharma

Sun Pharmaceutical

Aspen Pharmacare

Fresenius

Lupin

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Generic Drugs in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pure (Non-branded) Generics

Branded Generics

Super Generics

Split by application, this report focuses on sales, market share and growth rate of Generic Drugs in each application, can be divided into

Cardiovascular & Hypertension

Dermatology

Diabetes

Rheumatology

Oncology

Gastrointestinal

Others

Table of Contents

Europe Generic Drugs Market Report 2017

1 Generic Drugs Overview

1.1 Product Overview and Scope of Generic Drugs

1.2 Classification of Generic Drugs

1.2.1 Pure (Non-branded) Generics

1.2.2 Branded Generics

1.2.3 Super Generics

1.3 Application of Generic Drugs

1.3.1 Cardiovascular & Hypertension

1.3.2 Dermatology

1.3.3 Diabetes

1.3.4 Rheumatology

1.3.5 Oncology

1.3.6 Gastrointestinal

1.3.7 Others

1.4 Generic Drugs Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Generic Drugs (2011-2021)

1.5.1 Europe Generic Drugs Sales and Growth Rate (2011-2021)

1.5.2 Europe Generic Drugs Revenue and Growth Rate (2011-2021)

2 Europe Generic Drugs by Manufacturers, Type and Application

2.1 Europe Generic Drugs Market Competition by Manufacturers

2.1.1 Europe Generic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Generic Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Generic Drugs (Volume and Value) by Type

2.2.1 Europe Generic Drugs Sales and Market Share by Type (2011-2016)

2.2.2 Europe Generic Drugs Revenue and Market Share by Type (2011-2016)

2.3 Europe Generic Drugs (Volume and Value) by Countries

2.3.1 Europe Generic Drugs Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Generic Drugs Revenue and Market Share by Countries (2011-2016)

2.4 Europe Generic Drugs (Volume) by Application

3 Germany Generic Drugs (Volume, Value and Sales Price)

3.1 Germany Generic Drugs Sales and Value (2011-2016)

3.1.1 Germany Generic Drugs Sales and Growth Rate (2011-2016)

3.1.2 Germany Generic Drugs Revenue and Growth Rate (2011-2016)

3.1.3 Germany Generic Drugs Sales Price Trend (2011-2016)

3.2 Germany Generic Drugs Sales and Market Share by Manufacturers

3.3 Germany Generic Drugs Sales and Market Share by Type

3.4 Germany Generic Drugs Sales and Market Share by Application

4 France Generic Drugs (Volume, Value and Sales Price)

4.1 France Generic Drugs Sales and Value (2011-2016)

4.1.1 France Generic Drugs Sales and Growth Rate (2011-2016)

4.1.2 France Generic Drugs Revenue and Growth Rate (2011-2016)

4.1.4 France Generic Drugs Sales Price Trend (2011-2016)

4.2 France Generic Drugs Sales and Market Share by Manufacturers

4.3 France Generic Drugs Sales and Market Share by Type

4.4 France Generic Drugs Sales and Market Share by Application

5 UK Generic Drugs (Volume, Value and Sales Price)

5.1 UK Generic Drugs Sales and Value (2011-2016)

5.1.1 UK Generic Drugs Sales and Growth Rate (2011-2016)

5.1.2 UK Generic Drugs Revenue and Growth Rate (2011-2016)

5.1.5 UK Generic Drugs Sales Price Trend (2011-2016)

5.2 UK Generic Drugs Sales and Market Share by Manufacturers

5.3 UK Generic Drugs Sales and Market Share by Type

5.4 UK Generic Drugs Sales and Market Share by Application

6 Russia Generic Drugs (Volume, Value and Sales Price)

6.1 Russia Generic Drugs Sales and Value (2011-2016)

6.1.1 Russia Generic Drugs Sales and Growth Rate (2011-2016)

6.1.2 Russia Generic Drugs Revenue and Growth Rate (2011-2016)

6.1.6 Russia Generic Drugs Sales Price Trend (2011-2016)

6.2 Russia Generic Drugs Sales and Market Share by Manufacturers

6.3 Russia Generic Drugs Sales and Market Share by Type

6.4 Russia Generic Drugs Sales and Market Share by Application

7 Italy Generic Drugs (Volume, Value and Sales Price)

7.1 Italy Generic Drugs Sales and Value (2011-2016)

7.1.1 Italy Generic Drugs Sales and Growth Rate (2011-2016)

7.1.2 Italy Generic Drugs Revenue and Growth Rate (2011-2016)

7.1.7 Italy Generic Drugs Sales Price Trend (2011-2016)

7.2 Italy Generic Drugs Sales and Market Share by Manufacturers

7.3 Italy Generic Drugs Sales and Market Share by Type

7.4 Italy Generic Drugs Sales and Market Share by Application

8 Spain Generic Drugs (Volume, Value and Sales Price)

8.1 Spain Generic Drugs Sales and Value (2011-2016)

8.1.1 Spain Generic Drugs Sales and Growth Rate (2011-2016)

8.1.2 Spain Generic Drugs Revenue and Growth Rate (2011-2016)

8.1.8 Spain Generic Drugs Sales Price Trend (2011-2016)

8.2 Spain Generic Drugs Sales and Market Share by Manufacturers

8.3 Spain Generic Drugs Sales and Market Share by Type

8.4 Spain Generic Drugs Sales and Market Share by Application

9 Benelux Generic Drugs (Volume, Value and Sales Price)

9.1 Benelux Generic Drugs Sales and Value (2011-2016)

9.1.1 Benelux Generic Drugs Sales and Growth Rate (2011-2016)

9.1.2 Benelux Generic Drugs Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Generic Drugs Sales Price Trend (2011-2016)

9.2 Benelux Generic Drugs Sales and Market Share by Manufacturers

9.3 Benelux Generic Drugs Sales and Market Share by Type

9.4 Benelux Generic Drugs Sales and Market Share by Application

10 Europe Generic Drugs Manufacturers Analysis

10.1 Teva Pharma.

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Generic Drugs Product Type, Application and Specification

10.1.2.1 Pure (Non-branded) Generics

10.1.2.2 Branded Generics

10.1.3 Teva Pharma. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main BusinessBusiness Overview

10.2 Novartis company

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Generic Drugs Product Type, Application and Specification

10.2.2.1 Pure (Non-branded) Generics

10.2.2.2 Branded Generics

10.2.3 Novartis company Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main BusinessBusiness Overview

10.3 Mylan

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Generic Drugs Product Type, Application and Specification

10.3.2.1 Pure (Non-branded) Generics

10.3.2.2 Branded Generics

10.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main BusinessBusiness Overview

10.4 Allergan

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Generic Drugs Product Type, Application and Specification

10.4.2.1 Pure (Non-branded) Generics

10.4.2.2 Branded Generics

10.4.3 Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main BusinessBusiness Overview

10.5 Hospira

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Generic Drugs Product Type, Application and Specification

10.5.2.1 Pure (Non-branded) Generics

10.5.2.2 Branded Generics

10.5.3 Hospira Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main BusinessBusiness Overview

10.6 Dr. Reddy’s Lab.

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Generic Drugs Product Type, Application and Specification

10.6.2.1 Pure (Non-branded) Generics

10.6.2.2 Branded Generics

10.6.3 Dr. Reddy’s Lab. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main BusinessBusiness Overview

10.7 Stada

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Generic Drugs Product Type, Application and Specification

10.7.2.1 Pure (Non-branded) Generics

10.7.2.2 Branded Generics

10.7.3 Stada Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main BusinessBusiness Overview

10.8 Greenstone

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Generic Drugs Product Type, Application and Specification

10.8.2.1 Pure (Non-branded) Generics

10.8.2.2 Branded Generics

10.8.3 Greenstone Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main BusinessBusiness Overview

10.9 Par Pharma

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Generic Drugs Product Type, Application and Specification

10.9.2.1 Pure (Non-branded) Generics

10.9.2.2 Branded Generics

10.9.3 Par Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main BusinessBusiness Overview

10.10 Sun Pharmaceutical

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Generic Drugs Product Type, Application and Specification

10.10.2.1 Pure (Non-branded) Generics

10.10.2.2 Branded Generics

10.10.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main BusinessBusiness Overview

10.11 Aspen Pharmacare

10.12 Fresenius

10.13 Lupin

11 Generic Drugs Manufacturing Cost Analysis

11.1 Generic Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Generic Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Generic Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Generic Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, DistributorsTraders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 DistributorsTraders List

14 Europe Generic Drugs Market Forecast (2016-2021)

14.1 Germany Generic Drugs Sales Forecast (2016-2021)

14.2 France Generic Drugs Sales Forecast (2016-2021)

14.3 UK Generic Drugs Sales Forecast (2016-2021)

14.4 Russia Generic Drugs Sales Forecast (2016-2021)

14.5 Italy Generic Drugs Sales Forecast (2016-2021)

14.6 Spain Generic Drugs Sales Forecast (2016-2021)

14.7 Benelux Generic Drugs Sales Forecast (2016-2021)

14.8 Europe Generic Drugs Sales Forecast by Type (2016-2021)

14.9 Europe Generic Drugs Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Generic Drugs

Table Classification of Generic Drugs

Figure Europe Sales Market Share of Generic Drugs by Type in 2015

Figure Pure (Non-branded) Generics Picture

Figure Branded Generics Picture

Figure Super Generics Picture

Table Application of Generic Drugs

Figure Europe Sales Market Share of Generic Drugs by Application in 2015

Figure Cardiovascular & Hypertension Examples

Figure Dermatology Examples

Figure Diabetes Examples

Figure Rheumatology Examples

Figure Oncology Examples

Figure Gastrointestinal Examples

Figure Others Examples

Figure Germany Generic Drugs Revenue and Growth Rate (2011-2021)

Figure France Generic Drugs Revenue and Growth Rate (2011-2021)

Figure UK Generic Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Generic Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Generic Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Generic Drugs Revenue and Growth Rate (2011-2021)

Figure Benelux Generic Drugs Revenue and Growth Rate (2011-2021)

Figure Europe Generic Drugs Sales and Growth Rate (2011-2021)

Figure Europe Generic Drugs Revenue and Growth Rate (2011-2021)

Table Europe Generic Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Generic Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Generic Drugs Sales Share by Manufacturers

Figure 2016 Generic Drugs Sales Share by Manufacturers

Table Europe Generic Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Generic Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Generic Drugs Revenue Share by Manufacturers

Table 2016 Europe Generic Drugs Revenue Share by Manufacturers

Table Europe Generic Drugs Sales and Market Share by Type (2011-2016)

Table Europe Generic Drugs Sales Share by Type (2011-2016)

Figure Sales Market Share of Generic Drugs by Type (2011-2016)

Figure Europe Generic Drugs Sales Growth Rate by Type (2011-2016)

Table Europe Generic Drugs Revenue and Market Share by Type (2011-2016)

Table Europe Generic Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Generic Drugs by Type (2011-2016)

Figure Europe Generic Drugs Revenue Growth Rate by Type (2011-2016)

Table Europe Generic Drugs Sales and Market Share by Countries (2011-2016)

Table Europe Generic Drugs Sales Share by Countries (2011-2016)

Figure Sales Market Share of Generic Drugs by Countries (2011-2016)

Table Europe Generic Drugs Revenue and Market Share by Countries (2011-2016)

Table Europe Generic Drugs Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Generic Drugs by Countries (2011-2016)

Table Europe Generic Drugs Sales and Market Share by Application (2011-2016)

Table Europe Generic Drugs Sales Share by Application (2011-2016)

Figure Sales Market Share of Generic Drugs by Application (2011-2016)

Figure Germany Generic Drugs Sales and Growth Rate (2011-2016)

Figure Germany Generic Drugs Revenue and Growth Rate (2011-2016)

Figure Germany Generic Drugs Sales Price Trend (2011-2016)

Table Germany Generic Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Generic Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Generic Drugs Sales by Type (2015 and 2016)

Table Germany Generic Drugs Market Share by Type (2015 and 2016)

Table Germany Generic Drugs Sales by Application (2015 and 2016)

Table Germany Generic Drugs Market Share by Application (2015 and 2016)

Figure France Generic Drugs Sales and Growth Rate (2011-2016)

Figure France Generic Drugs Revenue and Growth Rate (2011-2016)

Figure France Generic Drugs Sales Price Trend (2011-2016)

Table France Generic Drugs Sales by Manufacturers (2015 and 2016)

Table France Generic Drugs Market Share by Manufacturers (2015 and 2016)

Table France Generic Drugs Sales by Type (2015 and 2016)

Table France Generic Drugs Market Share by Type (2015 and 2016)

Table France Generic Drugs Sales by Application (2015 and 2016)

Table France Generic Drugs Market Share by Application (2015 and 2016)

Figure UK Generic Drugs Sales and Growth Rate (2011-2016)

Figure UK Generic Drugs Revenue and Growth Rate (2011-2016)

Figure UK Generic Drugs Sales Price Trend (2011-2016)

Table UK Generic Drugs Sales by Manufacturers (2015 and 2016)

Table UK Generic Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Generic Drugs Sales by Type (2015 and 2016)

Table UK Generic Drugs Market Share by Type (2015 and 2016)

Table UK Generic Drugs Sales by Application (2015 and 2016)

Table UK Generic Drugs Market Share by Application (2015 and 2016)

Figure Russia Generic Drugs Sales and Growth Rate (2011-2016)

Figure Russia Generic Drugs Revenue and Growth Rate (2011-2016)

Figure Russia Generic Drugs Sales Price Trend (2011-2016)

Table Russia Generic Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Generic Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Generic Drugs Sales by Type (2015 and 2016)

Table Russia Generic Drugs Market Share by Type (2015 and 2016)

Table Russia Generic Drugs Sales by Application (2015 and 2016)

Table Russia Generic Drugs Market Share by Application (2015 and 2016)

Figure Italy Generic Drugs Sales and Growth Rate (2011-2016)

Figure Italy Generic Drugs Revenue and Growth Rate (2011-2016)

Figure Italy Generic Drugs Sales Price Trend (2011-2016)

Table Italy Generic Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Generic Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Generic Drugs Sales by Type (2015 and 2016)

Table Italy Generic Drugs Market Share by Type (2015 and 2016)

Table Italy Generic Drugs Sales by Application (2015 and 2016)

Table Italy Generic Drugs Market Share by Application (2015 and 2016)

Figure Spain Generic Drugs Sales and Growth Rate (2011-2016)

Figure Spain Generic Drugs Revenue and Growth Rate (2011-2016)

Figure Spain Generic Drugs Sales Price Trend (2011-2016)

Table Spain Generic Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Generic Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Generic Drugs Sales by Type (2015 and 2016)

Table Spain Generic Drugs Market Share by Type (2015 and 2016)

Table Spain Generic Drugs Sales by Application (2015 and 2016)

Table Spain Generic Drugs Market Share by Application (2015 and 2016)

Figure Benelux Generic Drugs Sales and Growth Rate (2011-2016)

Figure Benelux Generic Drugs Revenue and Growth Rate (2011-2016)

Figure Benelux Generic Drugs Sales Price Trend (2011-2016)

Table Benelux Generic Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Generic Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Generic Drugs Sales by Type (2015 and 2016)

Table Benelux Generic Drugs Market Share by Type (2015 and 2016)

Table Benelux Generic Drugs Sales by Application (2015 and 2016)

Table Benelux Generic Drugs Market Share by Application (2015 and 2016)

Table Generic Drugs Basic Information List

Table Teva Pharma. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Teva Pharma. Generic Drugs Sales Market Share (2011-2016)

Table Novartis company Basic Information List

Table Novartis company Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis company Generic Drugs Sales Market Share (2011-2016)

Table Mylan Basic Information List

Table Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mylan Generic Drugs Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Generic Drugs Sales Market Share (2011-2016)

Table Hospira Basic Information List

Table Hospira Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hospira Generic Drugs Sales Market Share (2011-2016)

Table Dr. Reddy’s Lab. Basic Information List

Table Dr. Reddy’s Lab. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dr. Reddy’s Lab. Generic Drugs Sales Market Share (2011-2016)

Table Stada Basic Information List

Table Stada Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Stada Generic Drugs Sales Market Share (2011-2016)

Table Greenstone Basic Information List

Table Greenstone Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Greenstone Generic Drugs Sales Market Share (2011-2016)

Table Par Pharma Basic Information List

Table Par Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Par Pharma Generic Drugs Sales Market Share (2011-2016)

Table Sun Pharmaceutical Basic Information List

Table Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sun Pharmaceutical Generic Drugs Sales Market Share (2011-2016)

Table Aspen Pharmacare Basic Information List

Table Fresenius Basic Information List

Table Lupin Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Generic Drugs

Figure Manufacturing Process Analysis of Generic Drugs

Figure Generic Drugs Industrial Chain Analysis

Table Raw Materials Sources of Generic Drugs Major Manufacturers in 2015

Table Major Buyers of Generic Drugs

Table Distributors/Traders List

Figure Germany Generic Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Germany Generic Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure France Generic Drugs Sales and Growth Rate Forecast (2016-2021)

Figure France Generic Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure UK Generic Drugs Sales and Growth Rate Forecast (2016-2021)

Figure UK Generic Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Generic Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Russia Generic Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Generic Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Italy Generic Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Generic Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Spain Generic Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Generic Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Generic Drugs Revenue and Growth Rate Forecast (2016-2021)

Table Europe Generic Drugs Sales Forecast by Type (2016-2021)

Table Europe Generic Drugs Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370